News
National Medicinal Plants Board and ICAR-National Bureau of Plant Genetic Resources ink MoU on plant genetic resource conservation
The purpose of this MoU is to conserve the Medicinal and Aromatic Plants Genetic Resources (MAPGRs) at designated space of ICAR-NBPGR.
Clinical trials for Regeneron's investigational double antibody cocktail for COVID-19 initiated
According to Regeneron, the Phase 3 trial will evaluate REGN-COV2's ability to prevent infection among uninfected people who have had close exposure to a COVID-19 patient
CSIR, Laxai Sciences to seek approval to undertake clinical trials of antiviral and host-directed combination therapies on Covid-19 patients
Dr Shekhar C. Mande has highlighted that this combinatorial strategy (antivirals and HDTs) with repurposed drugs having complementary, additive and synergistic role, has been adopted to increase therapeutic options for Covid-19 treatment.
AstraZeneca’s Dapagliflozin gets approval for treatment of Heart Failure patients with reduced ejection fraction
This is the first in class SGLT-2 inhibitor drug approved for the treatment of HFrEF and is the first drug proven to significantly reduce the risk of Cardiovascular death
Johns Hopkins finds positive result in COVID-19 ARDS treated patients with Cellenkos' Cord Blood cells
Physician-investigators at the Johns Hopkins University Hospital found promising data of treatment of COVID-19 induced ARDS with allogeneic, cord blood derived T-regulatory (Treg) cell therapy
BioEconomy Conclave 2026
